Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings

Original research
par
Dunlop, Adrian J. et al

Date de publication

2022

Géographie

Australia

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.

Constatations/points à retenir

This first study of depot buprenorphine in custodial settings showed treatment retention and outcomes comparable to those observed in community settings and for other opioid agonist treatment used in custodial settings, without increased risk of diversion.

La conception ou méthodologie de recherche

Open-label, non-randomized trial.

Mots clés

Outcomes
Legal system/law enforcement
Substitution/OAT
Diversion